文献速递肾小球疾病

补体因子H相关蛋白1在IgA肾病肾损伤中的双重作用

Dual Role of Factor H-Related Protein 1 in IgA Nephropathy Kidney Injury.
PubMed 文献 · Kidney Int Rep · 2025-10-08

本研究探讨FHR-1在IgA肾病相关肾损伤中的作用。体外实验显示致病性cIgA1-IC刺激后FHR-1与系膜细胞结合增强,促进C3c沉积,并通过补体依赖与非依赖途径诱导单核细胞分泌IL-1β和IL-18。小鼠模型证实FHR-1加重肾小球C3沉积和炎症细胞浸润,而FHR-1SCR1-2可减轻上述效应。

要点

  • FHR-1促进系膜细胞补体激活和炎症因子释放
  • FHR-1通过C3a-C3aR/C5a-C5aR及EMR2途径促炎
  • FHR-1SCR1-2可减轻FHR-1介导的肾损伤

核心结论

  • FHR-1通过加速补体激活和炎症加重IgA肾病肾损伤,FHR-1SCR1-2可有效减轻FHR-1诱导的炎症,具有治疗潜力。

研究设计与样本

  • 体外用人源系膜细胞与含IgA1免疫复合物共培养,体内用肝脏表达人FH和FHR-5的基因工程小鼠多次腹腔注射LCWE-CFA诱导IgA沉积。

主要发现

  • cIgA1-IC处理后FHR-1与系膜细胞结合增强并增加C3c沉积。
  • FHR-1刺激共培养单核细胞分泌更高水平IL-1β和IL-18,由C3a-C3aR和C5a-C5aR通路激活及与EMR2的非补体依赖相互作用介导。
  • 小鼠模型中腹腔注射FHR-1增加肾小球C3沉积、F4/80+巨噬细胞和Ly6G+中性粒细胞浸润,共注射FHR-1SCR1-2可减轻这些效应。

临床怎么用

  • FHR-1可作为IgA肾病肾损伤的潜在生物标志物和 therapeutic target。
  • FHR-1SCR1-2片段有望成为IgA肾病的新型治疗药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: IgA nephropathy (IgAN) is characterized by glomerular IgA deposition, inducing complement activation and inflammation. Previous investigations have highlighted the association of factor H (FH)-related protein 1 (FHR-1) with IgAN. Given the dual functionality of FHR-1, encompassing its "canonical function" in complement activation and "noncanonical function" in triggering inflammation, this study investigated the role of FHR-1 in IgAN-associated kidney injury. METHODS: In vitro experiments used IgA1-containing immune complexes (cIgA1-IC) to stimulate human mesangial cells, mimicking IgA deposition in IgAN, to explore FHR-1's interaction with impaired mesangial cells, its modulation of complement activation, and its proinflammatory impact when cocultured with monocytes. In vivo, a genetically engineered mouse model with the endogenous liver expression of human FH and FHR-5 received multiple low-dose intraperitoneal injections of Lactobacillus casei cell wall extract (LCWE)-CFA to induce IgA deposition. The nephrotoxic effects of FHR-1 and the therapeutic potential of partial FHR-1 short consensus repeat 1-2 (FHR-1SCR1-2) were assessed in this model. RESULTS: Following pathogenic cIgA1-IC treatment, FHR-1 demonstrated increased binding affinity to mesangial cells. Besides, FHR-1 augmented C3c deposition on mesangial cells. Upon bound to mesangial cells, FHR-1 stimulated cocultured monocytes to secrete higher levels of inflammatory cytokines, interleukin (IL)-1β and IL-18, mediated by complement activation-induced C3a-C3aR and C5a-C5aR pathway activation, and complement-independent interaction with EMR2 on monocytes. In the murine model, intraperitoneally injected FHR-1 heightened glomerular C3 deposition, F4/80+ macrophage, and Ly6G+ neutrophils infiltration, whereas coinjection with FHR-1SCR1-2 mitigated these effects. CONCLUSION: FHR-1 exacerbates kidney injury in IgAN by accelerating complement activation and inflammation. FHR-1SCR1-2 effectively attenuated FHR-1-induced inflammation, demonstrating promising therapeutic potential for IgAN.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Kang Y, Li X, Yuan X, et al. Dual Role of Factor H-Related Protein 1 in IgA Nephropathy Kidney Injury. Kidney Int Rep. 2025. PMID: 41541767. doi:10.1016/j.ekir.2025.09.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。